NTPCR

Cancer-related nucleoside-triphosphatase · Q9BSD7 · NTPCR on Sugi Atlas →

0 patent compounds predicted against NTPCR, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NTPCR by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
ALL SCTped FORUM - Pharmacogenomic Study (add-on Study) PHASE4UNKNOWN
Acelarin First Line Randomised Pancreatic Study PHASE2/PHASE3SUSPENDED
Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer PHASE3COMPLETED
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study) PHASE1/PHASE2RECRUITING
Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome PHASE2COMPLETED
Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene PHASE2COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia PHASE1/PHASE2COMPLETED
GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer PHASE2COMPLETED
Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer PHASE2COMPLETED
Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer PHASE2COMPLETED
Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer PHASE2UNKNOWN
A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung PHASE2COMPLETED
Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer PHASE2COMPLETED
Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment PHASE2COMPLETED
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma PHASE1UNKNOWN
Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors PHASE1COMPLETED
Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors PHASE1COMPLETED
Nucleoside Therapy in Patients With Telomere Biology Disorders PHASE1RECRUITING
Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression nanCOMPLETED
Tamoxifen Pharmacogenetics in Asian Breast Cancer Women nanUNKNOWN
DNA Adductomics for Colorectal Cancer Investigation nanUNKNOWN
Expression Levels of Nicotinamide Metabolism-related Protein (NMAP) in Newly Diagnosed Renal Cancer and Non-renal Cancer Populations nanUNKNOWN
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2 nanUNKNOWN
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas nanACTIVE_NOT_RECRUITING
The Roles of Neutrophil Elastase in Lung Cancer nanUNKNOWN
Hereditary Nonpolyposis Colorectal Cancer in Taiwan-Related Genetic Study and Clinical Applications nanUNKNOWN
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer nanUNKNOWN
Evaluation of Thymidine Kinase Activity in the Serum of Patients With Solid Tumors nanUNKNOWN
Thermogenic Silencer Regulatory Factors in Humans nanACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a NTPCR binder may also engage these)

ProteinNameSimilarity
Q1LZ78 1.000 Q1LZ78 →
Q9CQA9 0.997 Q9CQA9 →
Q08BL7 0.980 Q08BL7 →
Q8TB37 0.976 Q8TB37 →
Q5T6J7 0.975 Q5T6J7 →
Q9CWD8 0.975 Q9CWD8 →
Q9R060 0.975 Q9R060 →
Q9R061 0.974 Q9R061 →
Q6NTR1 0.974 Q6NTR1 →
Q8R123 0.974 Q8R123 →
Q80UN9 0.974 Q80UN9 →
Q9GZT8 0.973 Q9GZT8 →
Q0J7N5 0.972 Q0J7N5 →
Q9EQ80 0.972 Q9EQ80 →
Q9H3H1 0.972 Q9H3H1 →
Q24K00 0.972 Q24K00 →
Q76IC5 0.972 Q76IC5 →
Q9HAB8 0.971 Q9HAB8 →
Q5RCH4 0.971 Q5RCH4 →
Q68FS1 0.971 Q68FS1 →
Q8MIR4 0.971 Q8MIR4 →
Q5EAD2 0.971 Q5EAD2 →
TARS2 Threonine--tRNA ligase, mitochondrial 0.971 landscape →
A0JNU3 0.971 A0JNU3 →
Q940S3 0.971 Q940S3 →
Q0V9K2 0.970 Q0V9K2 →
Q8CGK3 0.970 Q8CGK3 →
Q32PY9 0.970 Q32PY9 →
Q86U10 0.970 Q86U10 →
A0A7N9VSG0 0.970 A0A7N9VSG0 →